Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
SCSocietal CDMO, Inc. logo

Societal CDMO, Inc. (SCTL)

NASDAQ Capital Market · Currency in USD
$1.10 ▲ +0.01 (+0.92%)
At close: Apr 5, 4:00 PM ET. Market closed.

Summary

Previous Close
$1.09
Open
$1.09
Day's Range
$1.09 – $1.10
52 Week Range
$0.26 – $1.28
Volume
512,703
Avg. Volume
1,139,311
Market Cap
$116.13M
Beta (5Y Monthly)
1.58
PE Ratio (TTM)
--
EPS (TTM)
-$0.14
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Societal CDMO, Inc.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Full-time employees
258
CEO
J. David Enloe Jr.

Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets.

Earnings

DateEst.Actual
May 8, 2024-$0.03-$0.06Miss
Mar 22, 2024-$0.01-$0.01Beat
Nov 8, 2023-$0.02-$0.05Miss
Aug 14, 2023-$0.03-$0.04Miss
May 10, 2023-$0.05-$0.06Miss
Mar 1, 2023-$0.05-$0.02Beat

Analyst view

Rating: Buy
Buy 57% · Hold 43% · Sell 0%

Get free alerts on SCTL and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.